News

Gustave Roussy among the top 5 best cancer hospitals in the world

Gustave Roussy is in 5th position worldwide and 1st hospital outside of the United States, according to the World’s Best Specialized Hospitals 2021 ranking by Newsweek magazine

Published on

World's Best Hospitals 2021

According to the World’s Best Specialized Hospitals 2021 ranking by Newsweek magazine, Gustave Roussy is in 5th position worldwide and 1st hospital outside of the United States. This ranking emphasizes the international recognition for excellence in care and powerful research performed by the Institute. It also means that patients, whose decision to choose the right hospital is determined mainly by the hospital’s reputation, can be confident and receive in France both the best care and the most effective clinical research.
 

"We are proud to be one of the world's top 5 cancer centers along with four American giants. This ranking is an important recognition of our savoir-faire and team expertise. Both our medical staff and scientists play an important part in making French healthcare one of the best in the world. Gustave Roussy has the ability to meet all the challenges of the 21st century: to detect, to study, to fight against, to care for and to overcome cancer" explains Professor Jean-Charles Soria, CEO of Gustave Roussy.

This new ranking reinforces Gustave Roussy's international reputation. Honored every year in the Clarivate ranking, with 10 of its experts featuring in the 2019 list of the world's most "Highly cited researchers". Gustave Roussy's physician-scientists are also regularly awarded prizes at international congresses by learned societies or major research organizations or foundations. Knowledge production is intensive, with 1,800 international publications, including more than 60 in highly cited papers (journal impact factor greater than 30).

Today, the Institute is a key player in the world for early trials, immunotherapy and precision medicine clinical trials. Nearly a quarter of Gustave Roussy's patients are part of a clinical study.

Today, by developing its new institutional strategic plan for the next ten years, Gustave Roussy is all geared up for the fight against cancer and the growing complexity of the disease, all for the benefit of their patients.

More about

► World’s Best Specialized Hospitals 2021 ranking

► Further information about the methodology

Last news

  • Two photon-counting CT scanners now equip Gustave Roussy's imaging department

    Since September 2026, Gustave Roussy's Department of Medical Imaging has been equipped with a second photon-counting CT scanner, delivering higher image resolution while reducing the doses of X-rays and contrast agent administered to patients. This technology recently enabled the Institute to perform an iodine-free pulmonary CT angiogram, a world first.

    Photographie du scanner à comptage photonique
  • Prevention and screening: getting ahead of lung cancer

    To mark Thoracic Cancer Awareness Month and Tobacco-Free Month, two campaigns focusing on lung cancer, Gustave Roussy highlights its initiatives to advance prevention and screening among people at increased risk. Since its creation in 2021, the Institute’s Interception Lung programme has welcomed more than 900 participants, supporting them to stop smoking and offering personalised screening for the disease.

    Photographie : patient effectuant un scanner thoracique et équipes soignantes
  • Gustave Roussy Meets His Audience

    As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.

    Deux personnes en charge de la collecte porte-à-porte
  • Mens November: Take care of your jewelry its precious!

    November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases. 

    Visuel fixe campagne novembre masculin